NHS National Generic Pharmaceuticals Wave 13
key details
| Value | £469,741,550 |
|---|---|
| Status | cancelled |
| Category (CPV) | 33600000 |
| Region | East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber |
| Deadline | 26 Jul 2021 |
| Contract start | 1 Feb 2022 |
| Contract end | 31 May 2024 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100 |
Awards (231)
This procurement was awarded to 133 suppliers. Values shown are per-award; the notice total is £469,741,550.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Accord-UK Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| ACIUM LTD shared | £469,741,550 | 30 Nov 2021 | active |
| ACIUM LTD shared | £469,741,518 | 30 Nov 2021 | active |
| Aguettant Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Aguettant Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Alissa Healthcare Research Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Alissa Healthcare Research Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Allergan shared | £469,741,550 | 30 Nov 2021 | active |
| Allergan shared | £469,741,518 | 30 Nov 2021 | active |
| Alliance Pharmaceuticals Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Alliance Pharmaceuticals Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Altan Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Altan Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Alturix shared | £1 | 30 Nov 2021 | active |
| Amarox Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Amarox Limited shared | £469,741,518 | 30 Nov 2021 | active |
| AOP Orphan Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| AOP Orphan Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Arcadia Pharma Ltd T/A Arcadia Medical shared | £469,741,550 | 30 Nov 2021 | active |
| Arcadia Pharma Ltd T/A Arcadia Medical shared | £469,741,518 | 30 Nov 2021 | active |
| Aristo Pharma Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Aristo Pharma Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Ascend Laboratories UK Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Ascend Laboratories UK Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Aspen Pharmacare UK Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Aspen Pharmacare UK Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Aspire Pharma Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Aspire Pharma Limited shared | £469,741,518 | 30 Nov 2021 | active |
| ATNAHS PHARMA UK LIMITED shared | £1 | 30 Nov 2021 | active |
| Aventis Pharma ltd t/a Sanofi shared | £469,741,550 | 30 Nov 2021 | active |
| Aventis Pharma ltd t/a Sanofi shared | £469,741,518 | 30 Nov 2021 | active |
| Baxter Healthcare Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Baxter Healthcare Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Bayer Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Bayer Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| B. Braun Medical Limited shared | £469,741,550 | 30 Nov 2021 | active |
| B. Braun Medical Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Beaumont Pharma Ltd shared | £1 | 30 Nov 2021 | active |
| Bowmed Ibisqus Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Bowmed Ibisqus Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Bristol Laboratories Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Bristol Laboratories Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Brown & Burk UK Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Brown & Burk UK Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| CHIESI LIMITED shared | £1 | 30 Nov 2021 | active |
| Cipla (EU) Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Cipla (EU) Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Clydesdale Pharma ltd shared | £1 | 30 Nov 2021 | active |
| Colonis Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Colonis Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Consilient Health Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Consilient Health Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Correvio GmbH shared | £1 | 30 Nov 2021 | active |
| Crescent Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Crescent Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| CST Pharma Limited shared | £469,741,550 | 30 Nov 2021 | active |
| CST Pharma Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Day Lewis Medical Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Day Lewis Medical Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Derma UK shared | £469,741,550 | 30 Nov 2021 | active |
| Derma UK shared | £469,741,518 | 30 Nov 2021 | active |
| Desitin Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Desitin Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Dexcel Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Dexcel Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Dr Falk Pharma UK Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Dr Falk Pharma UK Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Drugsrus Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Drugsrus Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| ennogen healthcare ltd shared | £469,741,550 | 30 Nov 2021 | active |
| ennogen healthcare ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Euro-Link Pharma Ltd shared | £1 | 30 Nov 2021 | active |
| FERNDALE PHARMACEUTICALS LIMITED shared | £469,741,518 | 30 Nov 2021 | active |
| Ferring Pharmaceuticals Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Ferring Pharmaceuticals Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Flexipharm Austrading Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Flexipharm Austrading Limited shared | £469,741,518 | 30 Nov 2021 | active |
| FLYNN PHARMA LIMITED shared | £1 | 30 Nov 2021 | active |
| FOCUS PHARMACEUTICALS LIMITED shared | £1 | 30 Nov 2021 | active |
| Fontus Health Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Fontus Health Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Fresenius Kabi Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Fresenius Kabi Limited shared | £469,741,518 | 30 Nov 2021 | active |
| GALEN LIMITED shared | £1 | 30 Nov 2021 | active |
| GlaxoSmithKline UK Limited shared | £469,741,550 | 30 Nov 2021 | active |
| GlaxoSmithKline UK Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Glenmark Pharmaceuticals Europe Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Glenmark Pharmaceuticals Europe Limited shared | £469,741,518 | 30 Nov 2021 | active |
| hameln pharma ltd shared | £469,741,550 | 30 Nov 2021 | active |
| hameln pharma ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Healthcare Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Healthcare Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| INTRAPHARM LABORATORIES LIMITED shared | £1 | 30 Nov 2021 | active |
| IPCA LABORATORIES UK LIMITED shared | £1 | 30 Nov 2021 | active |
| Kensington Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Kensington Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Kent Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Kent Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Kyowa Kirin Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Kyowa Kirin Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Laboratorio Reig Jofre SA shared | £469,741,550 | 30 Nov 2021 | active |
| Laboratorio Reig Jofre SA shared | £469,741,518 | 30 Nov 2021 | active |
| LEO Pharma shared | £469,741,550 | 30 Nov 2021 | active |
| LEO Pharma shared | £469,741,518 | 30 Nov 2021 | active |
| LogixX Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| LogixX Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Lucane Pharma shared | £469,741,550 | 30 Nov 2021 | active |
| Lucane Pharma shared | £469,741,518 | 30 Nov 2021 | active |
| Lundbeck Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Lundbeck Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Lupin Healthcare (UK) Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Lupin Healthcare (UK) Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Macleods Pharma UK Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Macleods Pharma UK Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Macure Pharma ApS shared | £469,741,550 | 30 Nov 2021 | active |
| Macure Pharma ApS shared | £469,741,518 | 30 Nov 2021 | active |
| Manx Healthcare Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Manx Healthcare Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Martindale Pharma shared | £469,741,550 | 30 Nov 2021 | active |
| Martindale Pharma shared | £469,741,518 | 30 Nov 2021 | active |
| medac Pharma LLP shared | £469,741,550 | 30 Nov 2021 | active |
| medac Pharma LLP shared | £469,741,518 | 30 Nov 2021 | active |
| MEDLEY PHARMA LIMITED shared | £1 | 30 Nov 2021 | active |
| Medreich PLC shared | £469,741,550 | 30 Nov 2021 | active |
| Medreich PLC shared | £469,741,518 | 30 Nov 2021 | active |
| Merck Sharpe & Dohme (UK) Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Merck Sharpe & Dohme (UK) Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Mercury Pharmaceuticals Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Mercury Pharmaceuticals Limited shared | £469,741,518 | 30 Nov 2021 | active |
| MIBE PHARMA UK LTD shared | £1 | 30 Nov 2021 | active |
| Milpharm Ltd/aurobinbdo shared | £469,741,550 | 30 Nov 2021 | active |
| Milpharm Ltd/aurobinbdo shared | £469,741,518 | 30 Nov 2021 | active |
| MIP Pharma GmbH shared | £469,741,550 | 30 Nov 2021 | active |
| MIP Pharma GmbH shared | £469,741,518 | 30 Nov 2021 | active |
| Morningside Pharmaeuticals shared | £469,741,550 | 30 Nov 2021 | active |
| Morningside Pharmaeuticals shared | £469,741,518 | 30 Nov 2021 | active |
| Mylan shared | £469,741,550 | 30 Nov 2021 | active |
| Mylan shared | £469,741,518 | 30 Nov 2021 | active |
| Napp Pharmaceuticals Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Napp Pharmaceuticals Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| NECESSITY SUPPLIES LIMITED shared | £1 | 30 Nov 2021 | active |
| Neon Healthcare Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Neon Healthcare Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Nexcape Pharmaceuticals Ltd. shared | £469,741,550 | 30 Nov 2021 | active |
| Nexcape Pharmaceuticals Ltd. shared | £469,741,518 | 30 Nov 2021 | active |
| Norgine Pharmaceuticals Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Norgine Pharmaceuticals Limited shared | £469,741,518 | 30 Nov 2021 | active |
| NORTHUMBRIA PHARMA LTD shared | £1 | 30 Nov 2021 | active |
| Noumed Life Sciences Limited shared | £1 | 30 Nov 2021 | active |
| Oralieve UK Ltd shared | £1 | 30 Nov 2021 | active |
| Organon Pharmaceuticals UK Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Organon Pharmaceuticals UK Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Panpharma UK Limited shared | £469,741,550 | 30 Nov 2021 | active |
| PANPHARMA UK LIMITED shared | £1 | 30 Nov 2021 | active |
| PARI shared | £469,741,550 | 30 Nov 2021 | active |
| PARI shared | £469,741,518 | 30 Nov 2021 | active |
| Pfizer Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Pfizer Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Phoenix Lab shared | £1 | 30 Nov 2021 | active |
| Pierre Fabre Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Pierre Fabre Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| P M PHARMA LTD shared | £1 | 30 Nov 2021 | active |
| Profile Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Profile Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Ranbaxy UK shared | £469,741,550 | 30 Nov 2021 | active |
| Ranbaxy UK shared | £469,741,518 | 30 Nov 2021 | active |
| Reckitt Benckiser shared | £469,741,550 | 30 Nov 2021 | active |
| Reckitt Benckiser shared | £469,741,518 | 30 Nov 2021 | active |
| Recordati Pharmaceuticals shared | £1 | 30 Nov 2021 | active |
| Recordati Rare Diseases UK Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Recordati Rare Diseases UK Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Relonchem Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Relonchem Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Rivopharm UK Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Rivopharm UK Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Roche Products Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Roche Products Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Roma Pharmaceuticals Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Roma Pharmaceuticals Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Rosemont Pharmaceuticals Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Rosemont Pharmaceuticals Limited shared | £469,741,518 | 30 Nov 2021 | active |
| RPH Pharmaceuticals AB shared | £469,741,550 | 30 Nov 2021 | active |
| RPH Pharmaceuticals AB shared | £469,741,518 | 30 Nov 2021 | active |
| Sandoz Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Sandoz Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| SCIECURE PHARMA LIMITED shared | £1 | 30 Nov 2021 | active |
| Seacross Pharmaceuticals Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Seacross Pharmaceuticals Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Selective Supplies Ltd. shared | £469,741,550 | 30 Nov 2021 | active |
| Selective Supplies Ltd. shared | £469,741,518 | 30 Nov 2021 | active |
| SINTETICA LIMITED shared | £1 | 30 Nov 2021 | active |
| Sobi (Swedish Orphan Biovitrum Ltd) shared | £1 | 30 Nov 2021 | active |
| Stragen UK Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Stragen UK Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Strides Pharma Uk LTD shared | £469,741,550 | 30 Nov 2021 | active |
| Strides Pharma Uk LTD shared | £469,741,518 | 30 Nov 2021 | active |
| Synchrony shared | £469,741,550 | 30 Nov 2021 | active |
| Synchrony shared | £469,741,518 | 30 Nov 2021 | active |
| Syri Limited (T/A Thame Laboratories) shared | £469,741,550 | 30 Nov 2021 | active |
| Syri Limited (T/A Thame Laboratories) shared | £469,741,518 | 30 Nov 2021 | active |
| TAKEDA UK LIMITED shared | £1 | 30 Nov 2021 | active |
| TETRIS PHARMA LTD shared | £1 | 30 Nov 2021 | active |
| Teva UK Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Teva UK Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Thea Pharmaceuticals Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Thea Pharmaceuticals Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Thornton and Ross Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Thornton and Ross Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| TILLOMED LABORATORIES LIMITED shared | £1 | 30 Nov 2021 | active |
| Torbay Pharmaceuticals shared | £469,741,550 | 30 Nov 2021 | active |
| Torbay Pharmaceuticals shared | £469,741,518 | 30 Nov 2021 | active |
| Torrent Pharma UK Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Torrent Pharma UK Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| TRANSDERMAL LIMITED shared | £1 | 30 Nov 2021 | active |
| TYPHARM LIMITED shared | £469,741,518 | 30 Nov 2021 | active |
| UPJOHN UK LIMITED shared | £1 | 30 Nov 2021 | active |
| VANTAGE PHARMACEUTICALS LTD shared | £1 | 30 Nov 2021 | active |
| V Pharma shared | £469,741,550 | 30 Nov 2021 | active |
| V Pharma shared | £469,741,518 | 30 Nov 2021 | active |
| Waverley Pharma Europe Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Waverley Pharma Europe Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Waymade PLC shared | £1 | 30 Nov 2021 | active |
| Wockhardt UK Limited shared | £469,741,550 | 30 Nov 2021 | active |
| Wockhardt UK Limited shared | £469,741,518 | 30 Nov 2021 | active |
| Zentiva Pharma UK Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Zentiva Pharma UK Ltd shared | £469,741,518 | 30 Nov 2021 | active |
| Zista Pharma Ltd shared | £469,741,550 | 30 Nov 2021 | active |
| Zista Pharma Ltd shared | £469,741,518 | 30 Nov 2021 | active |
description
Invitation to offer for NHS National Generic Pharmaceuticals Wave 13
Offer reference number: CM/PHG/17/5532
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
Transition (Everolimus)
CESW: 1 March 2022 - 30 September 2023 (19 months)
LSNE: 1 March 2022 - 31 January 2023 (11 months)
NWLN: 1 March 2022 - 31 January 2023 (11 months)
Oral Products plus non-parenterals
All Regions: 1 March 2022 - 31 May 2024 (27 months)
Hospital Only Products
CESW: 1 February 2022 - 30 September 2023 (20 months)
LSNE: 1 February 2022 - 31 May 2024 (28 months)
NWLN: 1 February 2022 - 31 January 2023 (12 months)
documents
- https://www.contractsfinder.service.gov.uk/Notice/2b45447f-b07a-4024-8b3a-2a2f2fd86749 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 19 Jan 2022 | Tender cancelled (tenderCancellation) | · | 2b45447f-b07a-4024-8b3a-2a2f2fd86749-502293 |
| 3 Aug 2022 | Award update (awardUpdate) | · | f872d76f-37e6-4b7e-b25e-c952ac8a42eb-560066 |
more from ATAMIS LTD
- Avon & Bedford Court 76-92 Church Street Weybridge, Surrey, KT13 8DL · £150,000 · 3 Mar 2026
- UKRI-5133 MRC LMB Microscope Servicing · £683,875 · 29 Aug 2025
- Assurance of SW's Management Approach Policies · £300,000 · 25 Nov 2024
- IFRS 16 lease valuations · £81,000 · 27 Sept 2024
- Microsoft Licences · £128,487 · 19 Sept 2024
- Programme Director Services · £92,575 · 19 Sept 2024
- Ward Boards software · £32,545 · 17 Sept 2024
- Carenotes- Right To Use- Licence · £319,923 · 16 Sept 2024
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.